SLU-PP-332 1mg x30 Capsules
ERR Agonist Exercise Mimetic for Metabolic and Endurance Research
SLU-PP-332 is a pan-ERR (Estrogen-Related Receptor) agonist that activates ERRα, ERRβ, and ERRγ to mimic the metabolic adaptations of aerobic exercise — increasing mitochondrial biogenesis, fat oxidation, and endurance capacity.
ERR Agonist Exercise Mimetic for Metabolic and Endurance Research
SLU-PP-332 activates the ERR family of nuclear receptors that regulate mitochondrial function and oxidative metabolism. Research shows it dramatically increases running endurance, mitochondrial density, and fat oxidation in sedentary animals — making it a powerful exercise mimetic.
As one of the most studied compounds in the metabolic & fat loss research space, SLU-PP-332 has attracted sustained scientific interest across Exercise mimetic research, ERR nuclear receptor studies, Mitochondrial biogenesis research. Peer-reviewed evidence indicates that dramatic endurance increase in sedentary mice, which has positioned SLU-PP-332 as a reference standard for researchers exploring exercise mimetic research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
SLU-PP-332 Documented Benefits: 3 Documented Mechanisms
ERR Pan-Agonism
Activates all three ERR isoforms (α, β, γ) to trigger comprehensive mitochondrial and metabolic adaptations.
Endurance Enhancement
Increases running endurance and oxidative capacity in animal studies without training.
Mitochondrial Biogenesis
Stimulates mitochondrial proliferation in skeletal muscle via PGC-1α/ERR axis.
How SLU-PP-332 Works: Molecular Mechanism & Pathway
Pan-ERR nuclear receptor agonist activating ERRα/β/γ to upregulate PGC-1α, mitochondrial biogenesis genes, and oxidative metabolism pathways mimicking aerobic exercise adaptations.
The 3 primary research pathways identified for SLU-PP-332 — ERR Pan-Agonism, Endurance Enhancement, Mitochondrial Biogenesis — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that activates all ERR isoforms unlike selective compounds, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, SLU-PP-332's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
SLU-PP-332 is routinely studied alongside AICAR and O-304 in metabolic & fat loss-focused compound panels. Researchers investigating exercise mimetic research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that promising exercise-in-a-pill candidate has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All SLU-PP-332 research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Dramatic endurance increase in sedentary mice
- Activates all ERR isoforms unlike selective compounds
- Promising exercise-in-a-pill candidate
Ideal For
- Exercise mimetic research
- ERR nuclear receptor studies
- Mitochondrial biogenesis research
- Metabolic syndrome studies
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on SLU-PP-332. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Dramatic endurance increase in sedentary mice
Activates all ERR isoforms unlike selective compounds
Promising exercise-in-a-pill candidate
Third-Party Verified Every Batch
Each vial of SLU-PP-332 is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
